Secondly, IL-17A inhibits CD4+ and CD8+ T cell infiltration in some tumor types and promotes infiltration of immune cells that exhibit immunosuppressive functions, like regulatory T cells and myeloid-derived suppressor cells. This evidence concerns the gene CD4 and neoplasm.